Village Landais Alzheimer, village that allows autonomy of people with Alzheimer

Publications Bank of innovations

Village Landais Alzheimer, village that allows autonomy of people with Alzheimer

Village Landais Alzheimer Public Interest Group

Imatge from Ehpadia website.

Residential complex with 105 people suffering from Alzheimer’s with a high degree of independence.

It is a small village designed exclusively to allow people with this disease to live autonomously, away from socio-sanitary centres and without the constant support of their relatives. Each inhabitant pays 24,000 euros per year and lives in a family-like house, despite sharing with other residents common spaces such as shops and a theater room. Sociosanitary care, on the other hand, is guaranteed by a group of professionals working there, as well as volunteers working in activities to promote the socialization of the residents.

The village is also a resource center for medical and therapeutic research, as studies are conducted there to assess the results and impacts of this innovative residential model.

Village Landais Alzheimer

Banc d’innovacions

PrevenSI, prevention of child sexual abuse

PrevenSI, prevention of child sexual abuse

Prevention of Sexual Child Abuse
Imatge d'una persona amb necessitats d'accessibilitat digital

Acctua, a technological solution promoting digital accessibility on the Internet

Acctua is a technological service that promotes digitial accessibility and digital inclusion.
Soy yo literal, a Digital Platform for Youth Mental Health

Soy yo literal, a Digital Platform for Youth Mental Health

Soy yo literal is a digital platform promoting mental health among young people
Fokus PI

FOKUS PI, an application that facilitates digital social planning

FOKUS PI is a a decision-making support tool for professionals in the social, healthcare, and educational sectors
BCI

BCI, a device that restores communication in patients with neurodegenerative diseases

The BCI is a technological innovation that restores communication in patients with neurodegenerative diseases